Posts Tagged ‘drugs’

FDA approves Cypress’ new cold medicines

MADISON — Cypress Pharmaceutical announced the Food and Drug Administration (FDA) has approved a new drug application (NDA) for Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution (CIII) and Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution (CIII). Both products are indicated for the relief of cough and symptoms associated with the common […] [...]

Cypress Pharmaceutical rolls out new generic drug

by Published: May 2,2011

Tags: drugs, manufacturing, medicine

MADISON — Cypress Pharmaceutical Inc. has commercially launched Epinastine HCl Ophthalmic Solution, 0.05%, which is AT-rated to Allergan’s ELESTAT (epinastine HCl ophthalmic solution) 0.05%. As the first company to file an abbreviated new drug application (ANDA) containing a paragraph IV certification for this product, Cypress has been awarded a 180-day period of marketing exclusivity. Cypress, […] [...]

Pharmacy group responds to Barbour signing S.B. 2445

by Published: May 2,2011

Tags: drugs, healthcare, pharmaceuticals, state government

JACKSON — The National Community Pharmacists Association (NCPA) has issued a statement regarding Gov. Haley Barbour signing into law S.B. 2445, which reauthorizes the Mississippi Pharmacy Practice Act and requires pharmacy benefit managers (PBMs) to be subject to oversight by the Mississippi Board of Pharmacy. B. Douglas Hoey, RPh, MBA, NCPA executive vice president and […] [...]

Pharmaceutical association’s ads target state lawmakers

by Published: March 20,2011

Tags: drugs, pharmaceuticals, pharmacies, state government

WASHINGTON — A new ad campaign by the Pharmaceutical Care Management Association (PCMA) “warns Mississippi legislators that SB 2445 would increase healthcare costs by granting the State Board of Pharmacy (instead of the State Insurance Commissioner) authority to regulate pharmacy benefit managers (PBMs).” This power transfer would create a conflict of interest since the board […] [...]

Settlement with drug companies could boost budget

JACKSON — Mississippi Attorney General Jim Hood says he hopes a new $20-million boost to the state from a pharmaceutical lawsuit will go to mental health services. House Appropriations Committee chairman Johnny Stringer agrees with the idea. He says the budget just happens to be short $20 million and that the funds would help support […] [...]

Pharmacy closing after 118 years in business

by Published: December 30,2010

Tags: drugs, healthcare, pharmacies, retail

AMORY — Peoples Drug Company will close the doors Dec. 31, ending its run as Amory’s oldest pharmacy in Amory. A pharmacy has existed in the same location on Main Street since 1892. The pharmacy burned in 1893 and was rebuilt in 1894. The only thing saved from the fire were blue apothecary jars that […] [...]

Pharmacy alumni establish new scholarship

by Published: December 22,2010

Tags: drugs, education, higher education, pharmacy, scholarships

OXFORD — To help the University of Mississippi School of Pharmacy recruit and retain qualified students, the Pharmacy Alumni Chapter of the UM Alumni Association has created a scholarship endowment bearing its name. The group plans to fund the endowment with proceeds from the annual pharmacy weekend golf tournament and gifts from other individuals and […] [...]

School of Pharmacy lands federal grant

by Published: November 18,2010

Tags: drugs, education, higher education, pharmacy, research

OXFORD — The University of Mississippi has received $31.7 million to expand the Thad Cochran Research Center, the primary research facility of the School of Pharmacy’s National Center for Natural Products Research. Larry Walker, NCNPR’s director since 2001, says the Health Resources and Services Administration and the U.S. Food and Drug Administration are providing $17.8 […] [...]

Pfizer offering $3.6B in cash for King Pharmaceuticals

by Published: October 12,2010

Tags: drugs, manufacturing, mergers and acquisitions

NEW YORK — Pfizer Inc., the world’s largest pharmaceutical company by revenue, said today it will buy pain drug maker King Pharmaceuticals Inc. for $3.6 billion in cash. Pfizer is paying $14.25 per share for King. That’s a premium of 40 percent to the stock’s yesterday closing price of $10.15. In the deal Pfizer gains […] [...]

Forty million doses of swine flu vaccine to be incinerated

by Published: July 1,2010

Tags: drugs, healthcare

ATLANTA — About a quarter of the swine flu vaccine produced for the U.S. public has expired — meaning that a whopping 40 million doses worth about $260 million is being written off as trash. “It’s a lot, by historical standards,” said Jerry Weir, who oversees vaccine research and review for the U.S. Food and […] [...]

« Previous Page Next Page »

Recent Posts


How ready is your business for health care reform?

View Results

The MBJ poll should not be considered a scientific one. Results reflect only the opinion of those who participate.

Loading ... Loading ...

Recent Comments